ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,809.91
      -0.15%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Revolution Medicines Inc (RVMD) Quote

      Revolution Medicines Inc

      Revolution Medicines Inc (RVMD)

      NASDAQ
      46.44
      0.88
      (1.93%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      46.44
      0.01
      (0.02%)
      After Hours: 4:00PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      46.44
      Bid
      45.90
      Ask
      47.25
      Volume
      1,099,305
      45.7975 Day's Range 46.82
      15.4401 52 Week Range 48.61
      Market Cap
      7.662B
      Previous Close
      45.56
      Open
      46.00
      Last Trade
      44
      @
      46.44
      Last Trade Time
      Financial Volume
      $ 51,036,874
      VWAP
      46.4265
      Average Volume (3m)
      1,548,569
      Shares Outstanding
      164,986,227
      Dividend Yield
      -
      PE Ratio
      -0.08
      Earnings Per Share (EPS)
      -2.64
      Revenue
      11.58M
      Net Profit
      -436.37M

      About Revolution Medicines Inc

      Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.revmed.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Revolution Medicines Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RVMD. The last closing price for Revolution Medicines was $45.56. Over the last year, Revolution Medicines shares have traded in a share price range of $ 15.4401 to $ 48.61.

      Revolution Medicines currently has 164,986,227 shares outstanding. The market capitalization of Revolution Medicines is $7.52 billion. Revolution Medicines has a price to earnings ratio (PE ratio) of -0.08.

      RVMD Latest News

      More News

      Form 8-K - Current report

      July 15 2024
      Edgar (US Regulatory)

      Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer

      Original research published in Cancer Discovery reveals a RAS(ON) multi-selective inhibitor exhibited robust anti-tumor activity alone or in combination with a RAS(ON) G12C-selective inhibitor in...

      July 11 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      July 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 10 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      July 09 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      July 09 2024
      Edgar (US Regulatory)

      Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024

      REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

      July 08 2024
      GlobeNewswire Inc.

      Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

      REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

      June 05 2024
      GlobeNewswire Inc.

      Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

      REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

      May 08 2024
      GlobeNewswire Inc.

      Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024

      REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

      May 01 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.10.21579628830446.3448.2945.37140573346.52595913CS
      48.1221.189979123238.3248.6136.5226966943.92099869CS
      126.4416.14048.6136.48154856941.27914014CS
      2618.6667.170626349927.7848.6126.95148866736.56894237CS
      5220.8481.4062525.648.6115.4401171251130.62106966CS
      15617.4760.303762512928.9748.6114.08112203027.13879803CS
      26017.0958.228279386729.3556.1814.0891016328.56393742CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      RVMD Discussion

      View Posts
      axelvento axelvento 4 months ago
      Dr Olive added: 'I’ve been working on pancreatic cancer for almost 20 years, and I’ve never seen preclinical results like these.

      'I think there is a real chance this approach will help change the standard of care for pancreatic cancer patients, but only clinical trials can determine that
      👍️0
      axelvento axelvento 4 months ago
      Breakthrough in fight against world's deadliest cancer - new drug shrunk up to 70% of pancreatic tumors in lab study

      https://www.dailymail.co.uk/health/article-13284461/pancreatic-cancer-breakthrough-deadliest-disease-study.html
      👍️0
      Monksdream Monksdream 4 months ago
      RVMD over $30
      👍️0
      Monksdream Monksdream 5 months ago
      RVMD 10Q. 2/26
      👍️0

      Your Recent History

      NASDAQ
      RVMD
      Revolution Medicines
      Delayed Upgrade Clock